| Literature DB >> 33650774 |
Christoph H Mayr1, Lukas M Simon2, Gabriela Leuschner1,3, Meshal Ansari1,2, Janine Schniering1,4, Philipp E Geyer5, Ilias Angelidis1, Maximilian Strunz1, Pawandeep Singh1, Nikolaus Kneidinger3, Frank Reichenberger6, Edith Silbernagel6, Stephan Böhm7, Heiko Adler8, Michael Lindner6,9, Britta Maurer4, Anne Hilgendorff10, Antje Prasse11, Jürgen Behr3,6, Matthias Mann5, Oliver Eickelberg12, Fabian J Theis2, Herbert B Schiller1.
Abstract
The correspondence of cell state changes in diseased organs to peripheral protein signatures is currently unknown. Here, we generated and integrated single-cell transcriptomic and proteomic data from multiple large pulmonary fibrosis patient cohorts. Integration of 233,638 single-cell transcriptomes (n = 61) across three independent cohorts enabled us to derive shifts in cell type proportions and a robust core set of genes altered in lung fibrosis for 45 cell types. Mass spectrometry analysis of lung lavage fluid (n = 124) and plasma (n = 141) proteomes identified distinct protein signatures correlated with diagnosis, lung function, and injury status. A novel SSTR2+ pericyte state correlated with disease severity and was reflected in lavage fluid by increased levels of the complement regulatory factor CFHR1. We further discovered CRTAC1 as a biomarker of alveolar type-2 epithelial cell health status in lavage fluid and plasma. Using cross-modal analysis and machine learning, we identified the cellular source of biomarkers and demonstrated that information transfer between modalities correctly predicts disease status, suggesting feasibility of clinical cell state monitoring through longitudinal sampling of body fluid proteomes.Entities:
Keywords: biomarker; data integration; fibrosis; proteomics; single-cell RNA-seq
Year: 2021 PMID: 33650774 DOI: 10.15252/emmm.202012871
Source DB: PubMed Journal: EMBO Mol Med ISSN: 1757-4676 Impact factor: 12.137